Most people know Ozempic and similar medications for helping manage type 2 diabetes and, in some cases, supporting weight loss. But researchers are beginning to explore another unexpected effect that could be just as significant.

Some people taking these medications report that they no longer have the same desire to drink alcohol.

While the research is still ongoing, here’s what experts know so far.

1. Some users report fewer alcohol cravings

Doctors say a growing number of patients taking medications like semaglutide and tirzepatide have noticed they simply aren’t as interested in drinking alcohol as they once were.

For some, that means drinking less often. Others say they’ve stopped drinking altogether.

2. It may affect the brain’s reward system

These medications belong to a class known as GLP-1 receptor agonists. They work by helping regulate appetite, but researchers believe they may also influence the brain’s reward pathways that are involved in cravings and addictive behaviors.

This could explain why some people report losing interest not only in food but also in alcohol.

3. Reduced cravings may extend beyond food

Experts note that some patients describe fewer cravings in general. Along with eating less, some report feeling less tempted by alcohol and even other reward-seeking behaviors.

However, scientists are still studying exactly why this happens and whether the effect is consistent across larger groups of people.

4. It’s not an approved treatment for alcohol addiction

Although these reports are encouraging, medications like Ozempic are not approved by the U.S. Food and Drug Administration (FDA) to treat alcohol use disorder.

Researchers say carefully designed clinical trials are still needed before these medications could be considered for that purpose.

5. These medications should only be used under medical supervision

Ozempic is approved to help manage type 2 diabetes, while another semaglutide medication, Wegovy, is approved for chronic weight management in eligible adults. They should only be taken under the guidance of a healthcare professional, who can determine whether they’re appropriate based on your medical history and health needs.

While weight loss remains their best-known benefit, researchers continue to uncover other ways these medications may affect the body and brain. The possible connection between GLP-1 medications and reduced alcohol cravings is promising, but more research is needed before any conclusions can be made or treatment recommendations change.